|
|
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1503-1506.
Prepublished online as a Blood First Edition Paper on October 10, 2006; DOI 10.1182/blood-2006-04-020362.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo
Ralph Tiedt1,
Tibor Schomber1,
Hui Hao-Shen1, and
Radek C. Skoda1
1 Department of Research and Experimental Hematology, University Hospital Basel, Switzerland
To generate transgenic mice that express Cre-recombinase exclusively in the megakaryocytic lineage, we modified a mouse bacterial artificial chromosome (BAC) clone by homologous recombination and replaced the first exon of the platelet factor 4 (Pf4), also called CXCL4, with a codon-improved Cre cDNA. Several strains expressing the transgene were obtained and one strain, Q3, was studied in detail. Crossing Q3 mice with the ROSA26-lacZ reporter strain showed that Cre-recombinase activity was confined to megakaryocytes. These results were further verified by crossing the Q3 mice with a strain containing loxP-flanked integrin ß1. Excision of this conditional allele in megakaryocytes was complete at the DNA level, and platelets were virtually devoid of the integrin ß1 protein. The Pf4-Cre transgenic strain will be a valuable tool to study megakaryopoiesis, platelet formation, and platelet function.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Happy to have the megakaryocyte blues
- Andrew D. Leavitt
Blood 2007 109: 1341.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Foller, S. Feil, K. Ghoreschi, S. Koka, A. Gerling, M. Thunemann, F. Hofmann, B. Schuler, J. Vogel, B. Pichler, et al.
Anemia and splenomegaly in cGKI-deficient mice
PNAS,
May 6, 2008;
105(18):
6771 - 6776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Italiano Jr
Megakaryocyte and platelet biology: getting your FAKs straight
Blood,
January 15, 2008;
111(2):
482 - 483.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Hitchcock, N. E. Fox, N. Prevost, K. Sear, S. J. Shattil, and K. Kaushansky
Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout
Blood,
January 15, 2008;
111(2):
596 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Petrich, P. Marchese, Z. M. Ruggeri, S. Spiess, R. A.M. Weichert, F. Ye, R. Tiedt, R. C. Skoda, S. J. Monkley, D. R. Critchley, et al.
Talin is required for integrin-mediated platelet function in hemostasis and thrombosis
J. Exp. Med.,
December 24, 2007;
204(13):
3103 - 3111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Leon, A. Eckly, B. Hechler, B. Aleil, M. Freund, C. Ravanat, M. Jourdain, C. Nonne, J. Weber, R. Tiedt, et al.
Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion
Blood,
November 1, 2007;
110(9):
3183 - 3191.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |